| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |